- Home
- ELTX vs EMCG Comparison
ELTX vs EMCG Comparison
Compare ELTX & EMCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTX
- EMCG
- Stock Information
- Founded
- ELTX 2011
- EMCG 2021
- Country
- ELTX United States
- EMCG United States
- Employees
- ELTX N/A
- EMCG N/A
- Industry
- ELTX Biotechnology: Pharmaceutical Preparations
- EMCG
- Sector
- ELTX Health Care
- EMCG
- Exchange
- ELTX Nasdaq
- EMCG NYSE
- Market Cap
- ELTX 54.6M
- EMCG 52.4M
- IPO Year
- ELTX 2021
- EMCG 2022
- Fundamental
- Price
- ELTX $8.54
- EMCG $11.93
- Analyst Decision
- ELTX Strong Buy
- EMCG
- Analyst Count
- ELTX 3
- EMCG 0
- Target Price
- ELTX $9.50
- EMCG N/A
- AVG Volume (30 Days)
- ELTX 59.5K
- EMCG 3.4K
- Earning Date
- ELTX 03-28-2025
- EMCG 01-01-0001
- Dividend Yield
- ELTX N/A
- EMCG N/A
- EPS Growth
- ELTX N/A
- EMCG N/A
- EPS
- ELTX N/A
- EMCG 0.23
- Revenue
- ELTX N/A
- EMCG N/A
- Revenue This Year
- ELTX N/A
- EMCG N/A
- Revenue Next Year
- ELTX N/A
- EMCG N/A
- P/E Ratio
- ELTX N/A
- EMCG $51.06
- Revenue Growth
- ELTX N/A
- EMCG N/A
- 52 Week Low
- ELTX $3.34
- EMCG $11.03
- 52 Week High
- ELTX $11.45
- EMCG $13.39
- Technical
- Relative Strength Index (RSI)
- ELTX 58.77
- EMCG 70.95
- Support Level
- ELTX $7.78
- EMCG $11.80
- Resistance Level
- ELTX $8.23
- EMCG $11.85
- Average True Range (ATR)
- ELTX 0.60
- EMCG 0.00
- MACD
- ELTX -0.15
- EMCG 0.01
- Stochastic Oscillator
- ELTX 55.14
- EMCG 100.00
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.
About EMCG EMBRACE CHANGE ACQUISITION CORP
Embrace Change Acquisition Corp is a blank check company. It is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses.